Daejeon, South Korea

Sang Yong Hong


 

 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Sang Yong Hong: Advancements in Pharmaceutical Compounds

Introduction

Sang Yong Hong, a prominent inventor based in Daejeon, South Korea, has made significant contributions to the field of pharmaceuticals. With two patents to his name, his innovations focus primarily on compounds with therapeutic potential in metabolic diseases.

Latest Patents

Sang Yong Hong's latest patents include the development of a 3-azabicyclo[3,1,1]heptane derivative, which features a pharmaceutical composition aimed at treating various metabolic diseases. This invention is particularly noted for its ketohexokinase (KHK) inhibitory activity, which is valuable in preventing or managing conditions such as diabetes, obesity, and nonalcoholic fatty liver disease.

Another noteworthy patent involves Dipeptidyl Peptidase-IV inhibiting compounds. These novel compounds demonstrate effective inhibitory action against DPP-IV, contributing to new methods of preparing these compounds and their pharmaceutical applications as active agents. The structural details of these compounds pave the way for their potential use in various therapeutic formulations.

Career Highlights

Throughout his career, Sang Yong Hong has collaborated with leading companies in the pharmaceutical industry, including LG Life Sciences and LG Chem. His work in these organizations has allowed him to develop and refine his innovative ideas, moving them from conception to practical application in drug development.

Collaborations

Sang Yong Hong has worked alongside notable colleagues such as Chang-Seok Lee and Jong Sung Koh. These collaborations highlight the collaborative nature of scientific research, facilitating the exchange of ideas and expertise that drive innovation in pharmaceuticals.

Conclusion

In conclusion, Sang Yong Hong stands out as a significant inventor in the pharmaceutical landscape. His recent patents exemplify the potential for innovation to address critical health challenges. As research continues to evolve, the impact of his contributions is likely to contribute positively to advancements in medical science and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…